Anne Altmeyer

Executive Director of Business Development
Novartis

Check out the incredible speaker line-up to see who will be joining Anne.

Download The Latest Agenda

Day 2

Sunday, April 10th, 2016

09:00 PANEL: Adapting Your Risk Tolerance And Decision-Making Behaviors In Response To Today’s Scientific And Deal-Making Landscape

• Exploring how the rapid pace of scientific innovation is impacting our industry

o Identifying the best ways to keep up and not be overwhelmed by the pace of scientific innovation

• Examining how biotech financing options have shifted over the past year

• Determining how companies need to adapt their risk tolerance and decision-making behaviors as a response to rapid scientific innovation and changes to biotech financing alternatives

• How have transactions become riskier and how can you minimize this risk?